Trinity Point Wealth, LLC Gilead Sciences, Inc. Transaction History

Trinity Point Wealth, LLC

  • $595 Million
  • Q1 2024

A detailed history of Trinity Point Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 5,886 shares of GILD stock, worth $392,537. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,886
Previous 5,708 3.12%
Holding current value
$392,537
Previous $462,000 6.71%
% of portfolio
0.07%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$71.58 - $87.29 $12,741 - $15,537
178 Added 3.12%
5,886 $431,000
Q4 2023

Feb 08, 2024
BUY
$73.27 - $83.09 $11,649 - $13,211
159 Added 2.87%
5,708 $462,000
Q3 2023

Nov 08, 2023
BUY
$73.94 - $80.67 $1,109 - $1,210
15 Added 0.27%
5,549 $415,000
Q2 2023

Aug 07, 2023
SELL
$76.01 - $86.7 $24,475 - $27,917
-322 Reduced 5.5%
5,534 $426,000
Q1 2023

May 04, 2023
BUY
$77.31 - $88.08 $5,102 - $5,813
66 Added 1.14%
5,856 $485,000
Q4 2022

Feb 07, 2023
BUY
$62.32 - $89.47 $39,697 - $56,992
637 Added 12.36%
5,790 $497,000
Q3 2022

Nov 09, 2022
BUY
$59.54 - $68.01 $17,981 - $20,539
302 Added 6.23%
5,153 $318,000
Q2 2022

Aug 05, 2022
BUY
$57.72 - $65.01 $1,904 - $2,145
33 Added 0.68%
4,851 $300,000
Q1 2022

May 13, 2022
BUY
$57.92 - $72.58 $521 - $653
9 Added 0.19%
4,818 $286,000
Q4 2021

Feb 11, 2022
BUY
$64.88 - $73.64 $7,526 - $8,542
116 Added 2.47%
4,809 $349,000
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $14,688 - $15,847
217 Added 4.85%
4,693 $328,000
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $8,251 - $9,015
130 Added 2.99%
4,476 $308,000
Q1 2021

May 11, 2021
SELL
$60.0 - $68.46 $3,240 - $3,696
-54 Reduced 1.23%
4,346 $281,000
Q4 2020

Feb 10, 2021
BUY
$56.65 - $64.55 $16,031 - $18,267
283 Added 6.87%
4,400 $293,000
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $3,912 - $4,919
63 Added 1.55%
4,117 $260,000
Q2 2020

Aug 13, 2020
SELL
$72.34 - $84.0 $27,923 - $32,424
-386 Reduced 8.69%
4,054 $312,000
Q1 2020

May 05, 2020
SELL
$62.63 - $80.22 $1.07 Million - $1.37 Million
-17,026 Reduced 79.32%
4,440 $332,000
Q4 2019

Feb 06, 2020
BUY
$61.62 - $67.78 $10,721 - $11,793
174 Added 0.82%
21,466 $1.4 Million
Q3 2019

Nov 07, 2019
BUY
$62.51 - $69.0 $9,063 - $10,005
145 Added 0.69%
21,292 $1.39 Million
Q2 2019

Aug 06, 2019
SELL
$61.87 - $69.38 $2,598 - $2,913
-42 Reduced 0.2%
21,147 $1.41 Million
Q1 2019

May 07, 2019
BUY
$62.53 - $70.05 $527,378 - $590,801
8,434 Added 66.12%
21,189 $1.38 Million
Q4 2018

Feb 11, 2019
BUY
$60.54 - $79.0 $772,187 - $1.01 Million
12,755 New
12,755 $798,000

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email